These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23299519)

  • 1. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
    Nathan H; Hyder O; Mayo SC; Hirose K; Wolfgang CL; Choti MA; Pawlik TM
    Ann Surg; 2013 Dec; 258(6):1022-7. PubMed ID: 23299519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
    Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
    J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.
    Zhang X; El-Serag HB; Thrift AP
    Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy.
    Gray SH; White JA; Li P; Kilgore ML; Redden DT; Abdel Aal AK; Simpson HN; McGuire B; Eckhoff DE; Dubay DA
    J Vasc Interv Radiol; 2017 Feb; 28(2):231-237.e2. PubMed ID: 27939085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
    Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
    J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
    Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
    J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.
    Sonnenday CJ; Dimick JB; Schulick RD; Choti MA
    J Gastrointest Surg; 2007 Dec; 11(12):1636-46; discussion 1646. PubMed ID: 17912593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.
    Davila JA; Duan Z; McGlynn KA; El-Serag HB
    J Clin Gastroenterol; 2012 Jan; 46(1):71-7. PubMed ID: 22157221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes after resection of alcohol-related versus hepatitis-related hepatocellular carcinoma: A SEER-Medicare database analysis.
    Mehta R; Tang Qinghe ; Tsilimigras DI; Paredes A; Dillhoff M; Cloyd JM; Ejaz A; Tsung A; Spolverato G; Pawlik TM
    Am J Surg; 2021 Jul; 222(1):167-172. PubMed ID: 33131693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.
    Shaya FT; Breunig IM; Seal B; Mullins CD; Chirikov VV; Hanna N
    Pharmacoeconomics; 2014 Jan; 32(1):63-74. PubMed ID: 24293197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
    Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
    Mironov O; Jaberi A; Kachura JR
    J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early stage hepatocellular carcinoma in the elderly: A SEER database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
    J Geriatr Oncol; 2017 Jul; 8(4):277-283. PubMed ID: 28389117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
    Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of non-surgical versus surgical therapy for localized hepatocellular carcinoma.
    Mohanty S; Rajaram R; Bilimoria KY; Salem R; Pawlik TM; Bentrem DJ
    J Surg Oncol; 2016 Feb; 113(2):175-80. PubMed ID: 26662882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for hepatocellular carcinoma: does it improve survival?
    Liu JH; Chen PW; Asch SM; Busuttil RW; Ko CY
    Ann Surg Oncol; 2004 Mar; 11(3):298-303. PubMed ID: 14993025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.
    Pawlik TM; Delman KA; Vauthey JN; Nagorney DM; Ng IO; Ikai I; Yamaoka Y; Belghiti J; Lauwers GY; Poon RT; Abdalla EK
    Liver Transpl; 2005 Sep; 11(9):1086-92. PubMed ID: 16123959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.